| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64c716d5da8cce86794cef1c7caee928
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22e61758d0d60fbc0a52c498b323b293 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355 |
| filingDate |
1996-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccdcb788cae98550d88aac759af4b7e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3de2f72373f921713643d59d312799b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f8f9e86db0c450bd614663b2553aede
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff9e4fd30b3fcd78c8760966cb17e09c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f7db56df4329aa3da67048e58db052e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a16a97426b43fc999ec9ddcd8bc4dc37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_893551fdbd837f3ce016893c7bc61b63 |
| publicationDate |
1999-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2136274-C1 |
| titleOfInvention |
Method of raising activity of systems of nonspecific biological protection of organism |
| abstract |
FIELD: medicine. SUBSTANCE: invention relates to methods of treatment of patients with infectious-septic diseases with the secondary immunodeficiency. To patients with carditis of different etiology and heart failure and concomitant chronic sepsis the following drugs are administrated for 10 days: ceruloplasmin at the dose 1.5 mg/kg every other day, reaferon at the dose 500000 IU by rectal route (two suppositoria per 24 h), vitamin E and tinalin at therapeutic doses. Method results to normalization of indices of an antioxidant protection and interferon status in these patients. EFFECT: enhanced effectiveness of method. 4 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0067782-A3 |
| priorityDate |
1996-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |